JPS62134092A - カルニチンの製造法 - Google Patents
カルニチンの製造法Info
- Publication number
- JPS62134092A JPS62134092A JP27518285A JP27518285A JPS62134092A JP S62134092 A JPS62134092 A JP S62134092A JP 27518285 A JP27518285 A JP 27518285A JP 27518285 A JP27518285 A JP 27518285A JP S62134092 A JPS62134092 A JP S62134092A
- Authority
- JP
- Japan
- Prior art keywords
- carnitine
- alkyl ester
- bacillus
- genus
- microorganism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960004203 carnitine Drugs 0.000 title claims abstract description 31
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title claims abstract 7
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 244000005700 microbiome Species 0.000 claims abstract description 15
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 6
- 241000589516 Pseudomonas Species 0.000 claims abstract description 6
- 241000186216 Corynebacterium Species 0.000 claims abstract description 5
- 241000192041 Micrococcus Species 0.000 claims abstract 3
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 239000000758 substrate Substances 0.000 abstract description 8
- 230000000813 microbial effect Effects 0.000 abstract description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003456 ion exchange resin Substances 0.000 abstract description 3
- 229920003303 ion-exchange polymer Polymers 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 241000193755 Bacillus cereus Species 0.000 abstract description 2
- 241000191938 Micrococcus luteus Species 0.000 abstract description 2
- 241000589540 Pseudomonas fluorescens Species 0.000 abstract description 2
- 241000228143 Penicillium Species 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 239000001963 growth medium Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 21
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 5
- -1 4-chloro-3-hydroxybutyrate ester Chemical class 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- YNOWULSFLVIUDH-UHFFFAOYSA-N 3-dehydrocarnitine Chemical compound C[N+](C)(C)CC(=O)CC([O-])=O YNOWULSFLVIUDH-UHFFFAOYSA-N 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 241000178960 Paenibacillus macerans Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000011437 continuous method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- GUYHPGUANSLONG-SNAWJCMRSA-N (E)-4-(trimethylammonio)but-2-enoate Chemical compound C[N+](C)(C)C\C=C\C([O-])=O GUYHPGUANSLONG-SNAWJCMRSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 102100033639 Acetylcholinesterase Human genes 0.000 description 1
- 108010022752 Acetylcholinesterase Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108010053652 Butyrylcholinesterase Proteins 0.000 description 1
- 241001660259 Cereus <cactus> Species 0.000 description 1
- 102100032404 Cholinesterase Human genes 0.000 description 1
- 241000186226 Corynebacterium glutamicum Species 0.000 description 1
- 244000044849 Crotalaria juncea Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101000876606 Homo sapiens Putative uncharacterized protein encoded by ERC2-IT1 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- RDHQFKQIGNGIED-MRVPVSSYSA-N O-acetyl-L-carnitine Chemical compound CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C RDHQFKQIGNGIED-MRVPVSSYSA-N 0.000 description 1
- 102100035223 Putative uncharacterized protein encoded by ERC2-IT1 Human genes 0.000 description 1
- JXXCENBLGFBQJM-FYZOBXCZSA-N [(2r)-3-carboxy-2-hydroxypropyl]-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)C[C@H](O)CC(O)=O JXXCENBLGFBQJM-FYZOBXCZSA-N 0.000 description 1
- 229960001009 acetylcarnitine Drugs 0.000 description 1
- 229940022698 acetylcholinesterase Drugs 0.000 description 1
- 102000005421 acetyltransferase Human genes 0.000 description 1
- 108020002494 acetyltransferase Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229960001518 levocarnitine Drugs 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27518285A JPS62134092A (ja) | 1985-12-09 | 1985-12-09 | カルニチンの製造法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP27518285A JPS62134092A (ja) | 1985-12-09 | 1985-12-09 | カルニチンの製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS62134092A true JPS62134092A (ja) | 1987-06-17 |
| JPH0555112B2 JPH0555112B2 (enExample) | 1993-08-16 |
Family
ID=17551816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP27518285A Granted JPS62134092A (ja) | 1985-12-09 | 1985-12-09 | カルニチンの製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS62134092A (enExample) |
-
1985
- 1985-12-09 JP JP27518285A patent/JPS62134092A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0555112B2 (enExample) | 1993-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0320460B1 (en) | Process for isolating the enzyme carnitinehydrolyase from strains belonging to the family enterobacteriaceae and use of the immobilized enzyme for producing L(-)-carnitine | |
| JPS62134092A (ja) | カルニチンの製造法 | |
| KR20010031894A (ko) | 크로토노베타인으로부터 ｌ-카르니틴을 생산하는 방법 | |
| JPH01148192A (ja) | カルニチンの製造法 | |
| SU763464A1 (ru) | Способ получени над-зависимой алкогольдегидрогеназы | |
| JP2840723B2 (ja) | ４‐ハロ‐３‐ヒドロキシブチロニトリルの製造法 | |
| JPH01144989A (ja) | コロミン酸の製造法 | |
| JP3715662B2 (ja) | 光学活性β−ヒドロキシカルボン酸及びその対掌体エステルの製造方法 | |
| SU553283A1 (ru) | Способ получени алкогольдегидрогеназы | |
| JPH067178A (ja) | ベンゾイルギ酸の製造方法 | |
| JPH01222798A (ja) | 光学活性カルボン酸及びその対掌体エステルの製造法 | |
| JP2946055B2 (ja) | 光学活性（ｓ）‐（＋）‐３‐ハロ‐１，２―プロパンジオールの製造法 | |
| SU966115A1 (ru) | Штамм рSеUDомоNаS меNDосINа 3121 продуцент холестеролэстеразы | |
| JPH08154692A (ja) | Ｄ−２−アミノ酪酸の製造方法 | |
| JPS62134093A (ja) | カルニチンの製造法 | |
| JPH01191697A (ja) | 光学活性カルボン酸及びその対掌体エステルの製造法 | |
| JPH0439316B2 (enExample) | ||
| JPH02257874A (ja) | ロドコッカス属細菌及びそれを用いる２―ヒドロキシ酪酸の製造法 | |
| JPH0424992B2 (enExample) | ||
| JPH0545235B2 (enExample) | ||
| JPS6269996A (ja) | カルニチン・アルキルエステルの製造法 | |
| JPH0279991A (ja) | Ｎ，ｎ’−ジアセチルキトビオースの製造方法 | |
| JPH01191696A (ja) | 光学活性カルボン酸及びその対掌体エステルの製造法 | |
| JPH02227074A (ja) | 新規なエキソ型加水分解酵素並びにイヌロトリオース及び／又はイヌロテトラオースの製造方法 | |
| JPS5921600B2 (ja) | Ｄ（−）−β−ヒドロキシイソ酪酸の製造方法 |